Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial of Vitamin B12 in Septic Shock
Sponsor: Medical College of Wisconsin
Summary
This study will randomize 20 septic shock patients to receive either a single 5 gram dose of IV vitamin B12 (Cyanokit® Meridian Medical Technologies, Columbia, MD) versus placebo in addition to standard of care to test the feasibility of completing clinical and laboratory protocols.
Official title: A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2019-08-05
Completion Date
2023-02-23
Last Updated
2026-05-27
Healthy Volunteers
No
Conditions
Interventions
Hydroxocobalamin
Single IV administration of Vitamin B12
Placebo
Single IV administration of saline
Locations (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, United States